Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study
Titel:
Single-Agent Oral Vinorelbine as First-Line Chemotherapy for Endocrine-Pretreated Breast Cancer With Bone Metastases and No Visceral Involvement: NORBREAST-228 Phase II Study
Auteur:
Steger, Guenther G. Dominguez, Adriana Dobrovolskaya, Natalia Giotta, Francesco Tubiana-Mathieu, Nicole Pecherstorfer, Martin Ardizzoia, Antonio Blasinska-Morawiec, Maria Espinosa, Enrique Villanova, Gustavo